Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,781 | -15,962 | -14,260 | -12,363 | -5,908 |
| Depreciation Amortization | -221 | -159 | 92 | 147 | 3 |
| Other Working Capital | 2,228 | 538 | -612 | 600 | -939 |
| Other Operating Activity | 961 | 1,235 | 2,012 | 1,024 | 1,192 |
| Operating Cash Flow | $-17,813 | $-14,347 | $-12,768 | $-10,592 | $-5,652 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,382 | -912 | 207 | -19,515 | N/A |
| PPE Investments | -13 | -19 | -28 | -16 | -16 |
| Investing Cash Flow | $3,369 | $-930 | $179 | $-19,531 | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 169 |
| Debt Issued | N/A | N/A | N/A | N/A | 109 |
| Common Stock Issued | 67 | N/A | 300 | 69,140 | 26,302 |
| Common Stock Repurchased | N/A | -500 | -2,482 | -940 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -4,784 | -2,914 |
| Financing Cash Flow | $67 | $-500 | $-2,183 | $63,416 | $23,665 |
| Exchange Rate Effect | -50 | -29 | -11 | 1 | N/A |
| Beginning Cash Position | 21,938 | 37,743 | 52,524 | 19,229 | 1,232 |
| End Cash Position | 7,511 | 21,938 | 37,743 | 52,524 | 19,229 |
| Net Cash Flow | $-14,427 | $-15,805 | $-14,781 | $33,295 | $17,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,813 | -14,347 | -12,768 | -10,592 | -5,652 |
| Capital Expenditure | -13 | -19 | -28 | -16 | -16 |
| Free Cash Flow | -17,826 | -14,365 | -12,795 | -10,607 | -5,668 |